Adamantinoma: studio di follow-up a lungo termine sulla storia naturale della malattia, risultati del trattamento e relazione con l'adamantinoma differenziato (dofol-like o adamantinoma giovanile)

Title

Code

ADAMANTINOMA

Type

Osservazionale

Start Year

2025

Status

In Corso

Principal Investigator

051-6366455

laura.campanacci@ior.it

Campanacci Laura, MD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. ADAMANTINOMA

Tuesday 15 July 2025, 14:55

PG0009594_2025_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Adamantinoma: studio di follow-up a lungo termine sulla storia naturale della malattia, risultati del trattamento e relazione con l'adamantinoma differenziato (dofol-like o adamantinoma giovanile)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Adamantinoma: studio di follow-up a lungo termine sulla storia naturale della malattia, risultati del trattamento e relazione con l'adamantinoma differenziato (dofol-like o adamantinoma giovanile)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in